Skip to content

Clinical trials

Recruiting Phase 2 Hematologic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Phase 2 Status: Recruiting Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20191
20201
20216
20222
20234
20249
202510
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
Tata Memorial Centre4
Memorial Sloan Kettering Cancer Center2
Nantes University Hospital2
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Cogent Biosciences, Inc.1
Fred Hutchinson Cancer Center1
Helsinki University Central Hospital1
Henry Ford Health System1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms36
Graft vs Host Disease9
Lymphoma, Non-Hodgkin6
Myelodysplastic Syndromes5
Leukemia, Myeloid, Acute4
Neoplasms4
Hodgkin Disease3
Hematologic Diseases2
Immune System Diseases2
Influenza, Human2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.